Clinical trial
The Glycocalyx in COVID-19 Patients. A Pilot Study
NCT05137249 is registered in ClinicalTrials.gov with Medical University of Vienna as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Glycocalyx in COVID-19 Patients. A Pilot Study
- Lead sponsor
- Medical University of Vienna
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 1, 2020
- Completion date
- May 1, 2021
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
coagulation disorder, covid-19, endothelial dysfunction